• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Heron Therapeutics, Inc. (HRTX)

    -NasdaqCM
    9.75 0.00(0.00%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:9.75
    Open:9.82
    Bid:9.74 x 1800
    Ask:9.75 x 900
    1y Target Est:19.00
    Beta:1.21
    Next Earnings Date:N/A
    Day's Range:9.64 - 9.83
    52wk Range:0.44 - 15.82
    Volume:66,944
    Avg Vol (3m):129,759
    Market Cap:284.50M
    P/E (ttm):N/A
    EPS (ttm):-2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HRTX

    Comparison

    Symbol% ChgMkt Cap
    HRTX 0.00%284.50M
    ALKSUp 2.78%8.44B
    DEPOUp 0.93%921.34M
    DRRXDown 1.64%90.56M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.97
    Quarterly EPS Est (Dec-14) :-0.79
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):-0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback